VTR
55
-3
WU
48
2
ACN
20
-2
DVN
43
-4
SWK
34
-8
BF.B
50
3
EQR
51
-2
DUK
59
2
IP
60
-4
PH
67
-2
FE
62
10
PM
64
2
LOW
49
10
MSI
55
5
WFC
74
-5
LB
57
-7
MTCH
35
-2
CHD
56
6
ORLY
69
3
AN
35
-3
VTR
55
-3
WU
48
2
ACN
20
-2
DVN
43
-4
SWK
34
-8
BF.B
50
3
EQR
51
-2
DUK
59
2
IP
60
-4
PH
67
-2
FE
62
10
PM
64
2
LOW
49
10
MSI
55
5
WFC
74
-5
LB
57
-7
MTCH
35
-2
CHD
56
6
ORLY
69
3
AN
35
-3
Financhill
Back

Lyft Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
40

LYFT
Lyft

Last Price:
$11.56
Seasonality Move:
-14.39%
Buy
53

SRPT
Sarepta Therapeutics

Last Price:
$70.37
Seasonality Move:
17.94%
Sell
40
Lyft (LYFT) is a Sell

Is Lyft a Buy, Sell or Hold?

  • The current Lyft [LYFT] share price is $12.14. The Score for LYFT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • LYFT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $71.81. The Score for SRPT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

LYFT Stock Price Chart

What is Lyft's stock price today?

  • The Lyft share price today is $12.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LYFT is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $71.81
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

LYFT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 46.98 Sell
Chaikin Money Flow: -7258334 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.71 - 12.93) Sell
Bollinger Bands (100): (12.34 - 16.04) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -9.92 Sell
Relative Strength Index (14 RSI): 28.2 Sell
Chaikin Money Flow: -798774 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (80.35 - 108.37) Sell
Bollinger Bands (100): (98.9 - 127.68) Sell

LYFT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.01 Buy
20-day SMA: 12.13 Buy
50-day SMA: 13.01 Sell
200-day SMA: 13.38 Sell
8-day EMA: 12.12 Buy
20-day EMA: 12.26 Sell
50-day EMA: 12.89 Sell
200-day EMA: 13.64 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 74.46 Sell
20-day SMA: 91.18 Sell
50-day SMA: 104.46 Sell
200-day SMA: 124.15 Sell
8-day EMA: 77.38 Sell
20-day EMA: 87.73 Sell
50-day EMA: 100.49 Sell
200-day EMA: 116.63 Sell

Lyft Earnings Growth & LYFT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and an increase next year of $0.34 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.

Lyft Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):